CD44 and neoplasm: Results of immunohistochemical studies have shown that the PC-3 xenograft tumor cells show a strong and diffuse positivity for CD44 similar to NEPC tumor cells compared with the LNCaP xenograft tumor cells, which show negativity for CD44 similar to bulk tumor cells derived from prostatic adenocarcinoma [51].